Win Some Lose Some lived up to his name by following up a loss with a victory for the third time in a row when he pounced ...

George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

Roche will use Dyno’s technology, through which Dyno applies AI and high-throughput in vivo data collection to engineering AAV capsids.

The "grave" of an undead white dwarf star is marked by a cosmic funeral wreath.

Roche has inked a new deal with Dyno Therapeutics to develop next-generation AAV capsids for gene therapies targeting ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. | In a new deal potentially ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy ...

Buoyed by their win over Munster, the Stormers now head into their clash against last season's champs with plenty of ...

Existing gene therapies have primarily used a small number of naturally occurring AAV vectors limited by low delivery efficiency as well as problems with pre-existing immunity and manufacturability.

Roche Holding AG is willing to pay more than $1 billion to solve one of the biggest challenges of gene therapy: delivery.The ...

The Championship's top three preview our visit to Buriram, and how crucial the PT Grand Prix of Thailand is to deciding the ...

Judge is a candidate to win the American League MVP award, but his performance in the postseason has been disappointing.